122 related articles for article (PubMed ID: 17312058)
1. 1H MR spectroscopy in the assessment of gliomatosis cerebri.
Guzmán-de-Villoria JA; Sánchez-González J; Muñoz L; Reig S; Benito C; García-Barreno P; Desco M
AJR Am J Roentgenol; 2007 Mar; 188(3):710-4. PubMed ID: 17312058
[TBL] [Abstract][Full Text] [Related]
2. Multivoxel magnetic resonance spectroscopy in gliomatosis cerebri.
Uysal E; Erturk M; Yildirim H; Karatag O; Can M; Tanik C; Basak M
Acta Radiol; 2005 Oct; 46(6):621-4. PubMed ID: 16334845
[TBL] [Abstract][Full Text] [Related]
3. Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy.
Weybright P; Sundgren PC; Maly P; Hassan DG; Nan B; Rohrer S; Junck L
AJR Am J Roentgenol; 2005 Dec; 185(6):1471-6. PubMed ID: 16304000
[TBL] [Abstract][Full Text] [Related]
4. Proton MR spectroscopy of gliomatosis cerebri: case report of elevated myoinositol with normal choline levels.
Saraf-Lavi E; Bowen BC; Pattany PM; Sklar EM; Murdoch JB; Petito CK
AJNR Am J Neuroradiol; 2003 May; 24(5):946-51. PubMed ID: 12748099
[TBL] [Abstract][Full Text] [Related]
5. Role of proton magnetic resonance spectroscopy in the diagnosis of gliomatosis cerebri: a unique pattern of normal choline but elevated Myo-inositol metabolite levels.
Mohana-Borges AV; Imbesi SG; Dietrich R; Alksne J; Amjadi DK
J Comput Assist Tomogr; 2004; 28(1):103-5. PubMed ID: 14716242
[TBL] [Abstract][Full Text] [Related]
6. MR spectroscopy in gliomatosis cerebri.
Bendszus M; Warmuth-Metz M; Klein R; Burger R; Schichor C; Tonn JC; Solymosi L
AJNR Am J Neuroradiol; 2000 Feb; 21(2):375-80. PubMed ID: 10696026
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive evaluation of cerebral glioma grade by using multivoxel 3D proton MR spectroscopy.
Zeng Q; Liu H; Zhang K; Li C; Zhou G
Magn Reson Imaging; 2011 Jan; 29(1):25-31. PubMed ID: 20832225
[TBL] [Abstract][Full Text] [Related]
8. Proton magnetic resonance spectroscopic findings of cerebral fat embolism induced by triolein emulsion in cats.
Baik SK; Kim YW; Kim HJ; Lee JW; Cho BM; Kim DH; Choi SH; Lee SH; Chang KH
Acta Radiol; 2008 Dec; 49(10):1174-81. PubMed ID: 19031181
[TBL] [Abstract][Full Text] [Related]
9. Spectroscopic evidence of cerebral axonopathy in patients with "pure" adrenomyeloneuropathy.
Dubey P; Fatemi A; Barker PB; Degaonkar M; Troeger M; Zackowski K; Bastian A; Smith SA; Pomper MG; Moser HW; Raymond GV
Neurology; 2005 Jan; 64(2):304-10. PubMed ID: 15668429
[TBL] [Abstract][Full Text] [Related]
10. The value of proton MR-spectroscopy in the differentiation of brain tumours from non-neoplastic brain lesions.
Aydin H; Sipahioğlu S; Oktay NA; Altin E; Kizilgöz V; Hekimoglu B
JBR-BTR; 2011; 94(1):1-10. PubMed ID: 21466053
[TBL] [Abstract][Full Text] [Related]
11. Value of diagnosis and differential diagnosis of MRI and MR spectroscopy in gliomatosis cerebri.
Yu A; Li K; Li H
Eur J Radiol; 2006 Aug; 59(2):216-21. PubMed ID: 16769190
[TBL] [Abstract][Full Text] [Related]
12. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
13. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
14. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
Elias AE; Carlos RC; Smith EA; Frechtling D; George B; Maly P; Sundgren PC
Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634
[TBL] [Abstract][Full Text] [Related]
15. Temporal window of metabolic brain vulnerability to concussion: a pilot 1H-magnetic resonance spectroscopic study in concussed athletes--part III.
Vagnozzi R; Signoretti S; Tavazzi B; Floris R; Ludovici A; Marziali S; Tarascio G; Amorini AM; Di Pietro V; Delfini R; Lazzarino G
Neurosurgery; 2008 Jun; 62(6):1286-95; discussion 1295-6. PubMed ID: 18824995
[TBL] [Abstract][Full Text] [Related]
16. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
[TBL] [Abstract][Full Text] [Related]
17. Evidence of reversible axonal dysfunction in systemic lupus erythematosus: a proton MRS study.
Appenzeller S; Li LM; Costallat LT; Cendes F
Brain; 2005 Dec; 128(Pt 12):2933-40. PubMed ID: 16195241
[TBL] [Abstract][Full Text] [Related]
18. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
[TBL] [Abstract][Full Text] [Related]
19. Metabolic changes in the normal ageing brain: consistent findings from short and long echo time proton spectroscopy.
Gruber S; Pinker K; Riederer F; Chmelík M; Stadlbauer A; Bittsanský M; Mlynárik V; Frey R; Serles W; Bodamer O; Moser E
Eur J Radiol; 2008 Nov; 68(2):320-7. PubMed ID: 17964104
[TBL] [Abstract][Full Text] [Related]
20. Use of proton magnetic resonance spectroscopy of the brain to differentiate gliomatosis cerebri from low-grade glioma.
Galanaud D; Chinot O; Nicoli F; Confort-Gouny S; Le Fur Y; Barrie-Attarian M; Ranjeva JP; Fuentès S; Viout P; Figarella-Branger D; Cozzone PJ
J Neurosurg; 2003 Feb; 98(2):269-76. PubMed ID: 12593610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
